Skip to main navigation
Skip to content
Skip to content
PDL Logo Blue Green
  • About PDL
  • Leadership
  • Investor Relations
  • About PDL
    • Management
  • Portfolio of Assets
  • Investor Relations
  • News
  • Contact

4

PDL  > Investor Relations > 4

SEC Filing Details

Document Details

Form
4
Filing Date
Dec 4, 2020
Document Date
Dec 3, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
PDL BioPharma, Inc.
Issuer
PDL BIOPHARMA, INC.
Filer
GRYSKA DAVID W

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

    Investor Relations

    • Frequently Asked Questions (FAQ)
    • Investor Updates
    • Press Releases
    • 2020 Proxy Statement
    • Tax Information
      • Common Stock Tax Information
      • Convertible Note Tax Information
    • SEC Filings
    • Contact Information

    Shareholder Tools

    • Printed Materials
    • Email Alerts
    • RSS
    • Print
    • Share
    • Search
    • Facebook
    • Google
    • LinkedIn
    • Twitter
    • RSS

PDL Logo White Fill

  • Terms of Use
  • Sitemap
© Copyright 2021 PDL BioPHARMA. All Rights Reserved.